Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia
- 15 April 2001
- Vol. 91 (8) , 1563-1567
- https://doi.org/10.1002/1097-0142(20010415)91:8<1563::aid-cncr1166>3.0.co;2-c
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Oral administration of cefixime to lower risk febrile neutropenic children with cancerCancer, 2000
- Oral versus Intravenous Empirical Antimicrobial Therapy for Fever in Patients with Granulocytopenia Who Are Receiving Cancer ChemotherapyNew England Journal of Medicine, 1999
- Outpatient treatment of fever and neutropenia for low risk pediatric cancer patientsCancer, 1999
- 1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained FeverClinical Infectious Diseases, 1997
- Early Discharge of Low‐Risk Febrile Neutropenic Children and Adolescents with CancerClinical Infectious Diseases, 1997
- Safety of early hospital discharge of selected febrile children and adolescents with cancer with prolonged neutropeniaMedical and Pediatric Oncology, 1997
- Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: Results of a prospective randomized trialThe American Journal of Medicine, 1995
- Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropeniaCancer, 1994
- The child with cancer and infection. I. Empiric therapy for fever and neutropenia, and preventive strategiesThe Journal of Pediatrics, 1991
- Approaching the controversies in antibacterial management of cancer patientsThe American Journal of Medicine, 1984